CD4 and tuberculosis: Both a higher CD4+ count at TB diagnosis (200 vs. 50 cells/μL, aOR 0.54, 95% CI 0.39 to 0.73) and BMI increase during anti‐TB treatment (2 vs. 0 kg/mg2, aOR 0.74, 95% CI 0.68 to 0.82) were associated with a decreased odds of unfavourable TB treatment outcomes in the multivariable model.